ArticleFrontiers in oncology2026
Evaluation of the accuracy of cone-beam CT-based dose calculation for target volumes and organs at risk in left-sided breast cancer radiotherapy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate dose calculation is essential in breast cancer radiotherapy. This study aimed to evaluate the feasibility and accuracy of cone-beam CT (CBCT) images with HU-relative electron density (HU-RED) correction for dose calculation in left-sided breast cancer radiotherapy. Methods: Twenty postoperative patients receiving adjuvant radiotherapy at Subei People's Hospital of Jiangsu Province (Yangzhou, China) from January 2022 to December 2024 were retrospectively enrolled. A patient-specific HU-RED calibration curve was generated using an improved density override method. Treatment plans created on planning CT (pCT) were transferred to CBCT for dose recalculation with identical optimization parameters. Dosimetric parameters of the planning target volume (PTV) and organs at risk (OARs) were compared. Two-dimensional gamma analysis was performed to assess dose consistency. Equivalence between CBCT- and pCT-based dose calculations was further evaluated using the two one-sided tests (TOST), Lin's concordance correlation coefficient (CCC), intraclass correlation coefficient (ICC), and Bland-Altman analysis. Results: Differences in PTV dosimetric indices (D2, D50, D98, Dmean, HI, CI) between CBCT- and pCT-based plans were small, with mean deviations <1.3% and no statistically significant differences ( Discussion: CBCT images corrected with HU-RED calibration achieved highly consistent dose calculation results compared with pCT in left-sided breast cancer radiotherapy. This method is feasible for clinical dose verification and may support future adaptive radiotherapy strategies, particularly with the integration of artificial intelligence techniques.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.